Harrow Inc (NASDAQ: HROW) kicked off on Monday, down -1.84% from the previous trading day, before settling in for the closing price of $57.48. Over the past 52 weeks, HROW has traded in a range of $7.60-$59.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 27.34% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 44.33%. With a float of $30.34 million, this company’s outstanding shares have now reached $35.17 million.
In an organization with 315 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 71.16%, operating margin of -5.29%, and the pretax margin is -20.71%.
Harrow Inc (HROW) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Harrow Inc is 14.48%, while institutional ownership is 53.65%. The most recent insider transaction that took place on Apr 25 ’24, was worth 199,400. In this transaction 10% Owner of this company bought 20,000 shares at a rate of $9.97, taking the stock ownership to the 3,815,000 shares. Before that another transaction happened on Apr 23 ’24, when Company’s 10% Owner bought 11,715 for $10.29, making the entire transaction worth $120,547. This insider now owns 3,786,715 shares in total.
Harrow Inc (HROW) Latest Financial update
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.13 earnings per share (EPS), lower than consensus estimate (set at 0.03) by -0.16. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.33% per share during the next fiscal year.
Harrow Inc (NASDAQ: HROW) Trading Performance Indicators
Take a look at Harrow Inc’s (HROW) current performance indicators. Last quarter, stock had a quick ratio of 2.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.99.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.95, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 1.03 in one year’s time.
Technical Analysis of Harrow Inc (HROW)
Let’s dig in a bit further. During the last 5-days, its volume was 0.54 million. That was better than the volume of 0.49 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 82.76%. Additionally, its Average True Range was 2.44.
During the past 100 days, Harrow Inc’s (HROW) raw stochastic average was set at 93.39%, which indicates a significant increase from 81.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.83% in the past 14 days, which was lower than the 83.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.59, while its 200-day Moving Average is $22.47. However, in the short run, Harrow Inc’s stock first resistance to watch stands at $57.31. Second resistance stands at $58.20. The third major resistance level sits at $58.92. If the price goes on to break the first support level at $55.70, it is likely to go to the next support level at $54.98. The third support level lies at $54.09 if the price breaches the second support level.
Harrow Inc (NASDAQ: HROW) Key Stats
The company with the Market Capitalisation of 2.00 billion has total of 35,382K Shares Outstanding. Its annual sales at the moment are 130,190 K in contrast with the sum of -24,410 K annual income. Company’s last quarter sales were recorded 48,940 K and last quarter income was -6,470 K.
